171 related articles for article (PubMed ID: 31882504)
1. Multiparametric MRI
Pepe P; Dibenedetto G; Pepe L; Pennisi M
In Vivo; 2020; 34(1):393-396. PubMed ID: 31882504
[TBL] [Abstract][Full Text] [Related]
2. A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.
Hendriks RJ; van der Leest MMG; Dijkstra S; Barentsz JO; Van Criekinge W; Hulsbergen-van de Kaa CA; Schalken JA; Mulders PFA; van Oort IM
Prostate; 2017 Oct; 77(14):1401-1407. PubMed ID: 28853167
[TBL] [Abstract][Full Text] [Related]
3. Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy.
Busetto GM; Del Giudice F; Maggi M; De Marco F; Porreca A; Sperduti I; Magliocca FM; Salciccia S; Chung BI; De Berardinis E; Sciarra A
World J Urol; 2021 Jun; 39(6):1869-1877. PubMed ID: 32681273
[TBL] [Abstract][Full Text] [Related]
4. Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Barbera M; Panella P; Pennisi M; Morgia G
Arch Ital Urol Androl; 2016 Dec; 88(4):300-303. PubMed ID: 28073197
[TBL] [Abstract][Full Text] [Related]
5. Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?
Pepe P; Garufi A; Priolo G; Pennisi M
World J Urol; 2016 Sep; 34(9):1249-53. PubMed ID: 26699628
[TBL] [Abstract][Full Text] [Related]
6. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
[TBL] [Abstract][Full Text] [Related]
7. Which Prostate Biopsy in Men Enrolled in Active Surveillance? Experience in 110 Men Submitted to Scheduled Three-Years Transperineal Saturation Biopsy Combined With Fusion Targeted Cores.
Pepe P; Pepe L; Pennisi M; Fraggetta F
Clin Genitourin Cancer; 2021 Aug; 19(4):305-308. PubMed ID: 33642223
[TBL] [Abstract][Full Text] [Related]
8. SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study.
Maggi M; Del Giudice F; Falagario UG; Cocci A; Russo GI; Di Mauro M; Sepe GS; Galasso F; Leonardi R; Iacona G; Carroll PR; Cooperberg MR; Porreca A; Ferro M; Lucarelli G; Terracciano D; Cormio L; Carrieri G; De Berardinis E; Sciarra A; Busetto GM
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922626
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer.
Otti VC; Miller C; Powell RJ; Thomas RM; McGrath JS
BJU Int; 2019 Jan; 123(1):82-90. PubMed ID: 29804315
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men.
Hendriks RJ; van der Leest MMG; Israël B; Hannink G; YantiSetiasti A; Cornel EB; Hulsbergen-van de Kaa CA; Klaver OS; Sedelaar JPM; Van Criekinge W; de Jong H; Mulders PFA; Crawford ED; Veltman J; Schalken JA; Barentsz JO; van Oort IM
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1110-1119. PubMed ID: 33941866
[TBL] [Abstract][Full Text] [Related]
11. Confirmatory transperineal saturation prostate biopsy combined with mpMRI decrease the reclassification rate in men enrolled in Active Surveillance: Our experience in 100 men submitted to eight-years scheduled biopsy.
Pepe P; Pepe L; Pennisi M; Fraggetta F
Arch Ital Urol Androl; 2022 Sep; 94(3):270-273. PubMed ID: 36165468
[TBL] [Abstract][Full Text] [Related]
12. Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx?
Rahnama'i MS; Bach C; Schulze-Hagen M; Kuhl CK; Vögeli TA
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1396. PubMed ID: 33931984
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-PSMA PET/CT evaluation in men enrolled in prostate cancer Active Surveillance.
Pepe P; Pepe L; Tamburo M; Marletta G; Savoca F; Pennisi M; Fraggetta F
Arch Ital Urol Androl; 2023 May; 95(2):11322. PubMed ID: 37212907
[TBL] [Abstract][Full Text] [Related]
14. Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancer.
Katzendorn O; von Klot CAJ; Mahjoub S; Faraj Tabrizi P; Harke NN; Tezval H; Hellms S; Hennenlotter J; Baig MS; Stenzl A; Seith F; Lafos M; Kuczyk MA; Rausch S; Peters I
PLoS One; 2022; 17(8):e0271981. PubMed ID: 35960727
[TBL] [Abstract][Full Text] [Related]
15. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
[TBL] [Abstract][Full Text] [Related]
16. Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports.
Minnee P; Hessels D; Schalken JA; Van Criekinge W
BMC Urol; 2019 Nov; 19(1):124. PubMed ID: 31783839
[TBL] [Abstract][Full Text] [Related]
17. How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy.
Pepe P; Pennisi M; Fraggetta F
Urology; 2020 Mar; 137():133-137. PubMed ID: 31758981
[TBL] [Abstract][Full Text] [Related]
18. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?
Pepe P; Garufi A; Priolo G; Pennisi M
Clin Genitourin Cancer; 2015 Feb; 13(1):e27-30. PubMed ID: 25081324
[TBL] [Abstract][Full Text] [Related]
19. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis.
Sari Motlagh R; Yanagisawa T; Kawada T; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Huebner NA; Baltzer PA; Karakiewicz PI; Heidenreich A; Shariat SF
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):187-198. PubMed ID: 35414118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
